Clinical research on prediction marker of efficacy in advanced non-small cell lung cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 581-584, 2010.
Artículo
en Chino
| WPRIM
| ID: wpr-383366
ABSTRACT
Individualized therapy is the current trend of treatment in advanced non-small cell lung cancer, the key of individualized therapy is to administrer different treatment options through different biological markers or clinical markers. Currently, biological markers include EGFR protein expression, EGFR mutations, EGFR gene copy, k-ras mutation, EML4-ALK gene fusion, C-MET gene. Clinical markers include rash, pathological types, etc. This article will give a review about those biomarkers.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio pronóstico
Idioma:
Chino
Revista:
Cancer Research and Clinic
Año:
2010
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS